KNTE News and Press, Kinnate Biopharma Inc. From 11/09/23

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Kinnate Biopharma Inc. (KNTE) is expected to report $-0.69 for Q3 2023

2023-09-19 08:25:16 ET Losers: Rocket Lab USA ( RKLB ) -24% after launch failure leads to a loss of payload. Digital Transformation Opportunities Corp. ( DTOC ) -23% . Terran Orbital Corporation ( LLAP ) -18% prices $32.5M stock offering . E...

2023-09-18 19:28:41 ET More on Kinnate Biopharma Seeking Alpha’s Quant Rating on Kinnate Biopharma Historical earnings data for Kinnate Biopharma Financial information for Kinnate Biopharma Kinnate Biopharma: More A Bet Than An Investment At This Early...

Promising exarafenib combination data in NRAS mutant melanoma; intend to select two doses in the fourth quarter of 2023 for further development Plan to file KIN-8741 c-MET inhibitor Investigational New Drug application and nominate a drug candidate for brain-penetrant CDK4 selective progr...

2023-09-03 05:26:58 ET Summary Kinnate Biopharma is a precision oncology biotech with a unique approach to targeted therapy, but faces challenges in financing and cash burn. The company's pipeline includes a drug called exarafenib, which has shown promise in targeting various muta...

2023-08-08 17:57:31 ET Kinnate Biopharma press release ( NASDAQ: KNTE ): Q2 GAAP EPS of -$0.68 beats by $0.08 . As of June 30, 2023, total cash, cash equivalents and investments were $204.3 million, which is expected to fund current operations into early 2025. Fo...

Received FDA clearance of IND application for brain-penetrant MEK inhibitor, KIN-7136; expect to enter the clinic with Phase 1 trial in the second half of 2023 Cash, cash equivalents and investments of $204.3 million as of June 30, 2023 anticipated to fund operations into early 2025 ...

2023-06-22 17:31:01 ET Gainers: Trupanion ( TRUP ) +15% . Stronghold Digital Mining ( SDIG ) +6% . Pinduoduo ( PDD ) +6% . CareMax ( CMAX ) +5% . Seer ( SEER ) +4% . Losers: Kinnate Biopharma ( KNTE ) -5% . Ca...

2023-06-11 09:51:51 ET Summary Shares of precision oncology concern Kinnate Biopharma Inc. (KNTE) have crashed 93% from their all-time high as long overdue data from a Phase 1 study failed to impress. The company is advancing a couple of early-stage compounds but has hit some bump...